Don Enns

Jun 18, 2019

Microbiome Insights has appointed Don Enns as an independent member of its board of directors. Enns currently serves as VP and head of global drug delivery at Evonik Industries, joining the firm in 2016 with its acquisition of Transferra Nanoscience, where he served as president and CEO. Prior to Transferra, Enns was president and CEO at Cantest before the firm was acquired by Maxxam Analytics in 2009.

Breaking News

People in the News at Illumina, Beckman Coulter, Oxford Nanopore, Quanterix, Akoya, Nuclera, More
New Products Posted to GenomeWeb: Sphere Fluidics, Children's Mercy KC, LGC, Genomenon
Editas Medicine Raises $57M by Selling Future Payments From CRISPR Licensing Deal With Vertex Pharma
In Brief This Week: Pacific Biosciences, Macrogen, Dovetail Genomics, Bionano Genomics, More
Exact Sciences Nabs FDA Approval for Cologuard Plus Assay

Don Enns

People in the News at Illumina, Beckman Coulter, Oxford Nanopore, Quanterix, Akoya, Nuclera, More

New Products Posted to GenomeWeb: Sphere Fluidics, Children's Mercy KC, LGC, Genomenon

Editas Medicine Raises $57M by Selling Future Payments From CRISPR Licensing Deal With Vertex Pharma

In Brief This Week: Pacific Biosciences, Macrogen, Dovetail Genomics, Bionano Genomics, More

Exact Sciences Nabs FDA Approval for Cologuard Plus Assay